STAT+: Pharmalittle: Appeals court allows access to abortion pill, but with restrictions; FDA official intervened on behalf of Sarepta gene therapy
A U.S. appeals court is allowing continued access to the abortion pill mifepristone, but with some added restrictions.
by Ed Silverman
Apr 13, 2023
1 minute
Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot campus than from our ritual cup of stimulation — our choice
You’re reading a preview, subscribe to read more.
Start your free 30 days